Expert Q&A We Cannot End Overdoses Until We Achieve Racial Justice: Q&A with Julie Rwan Julie Rwan, Senior Manager for the Overdose Prevention Program’s Michigan team explains what executive actions hope to accomplish, how this impacts overdose prevention work, and why addressing racism in public health is paramount.
Expert Q&A How Turkey’s Game-Changing Legislation Delivers Powerful Free Airtime for Anti-Tobacco Campaigns Tuba Durgut, a Vital Strategies consultant based in Istanbul, discusses a powerful, cost-effective way to get tobacco control messages to millions of citizens in Turkey, and provides tips for other countries to create sustainable mechanisms of their own.
Expert Q&A The Importance of Supply Chain Management in Clinical Trials Jan Komrska and Ishmael Qawiy, Pharmacists for the Research Division at Vital Strategies discuss the significance of clinical trial supply chain management, how COVID-19 is affecting them and ways in which they can be strengthened.
Expert Q&A Harm Reduction Emphasized in Pennsylvania Governor’s Strategic Plan to Reduce Overdose We sat down with Katie Merritt, our Overdose Prevention and Response Coordinator to learn more about the governor’s strategic plan, the focus on harm reduction, and Vital Strategies’ work to reduce overdose deaths.
Expert Q&A Vital Strategies Releases Guidance to Reduce Both COVID-19 and Overdose Deaths: Q&A with Daliah Heller Daliah Heller, Director of Drug Use Initiatives at Vital Strategies discusses how COVID-19 has impacted people who use drugs and how states can encourage harm reduction during the pandemic.
Expert Q&A Naloxone Trainings are Crucial to Saving Lives from Overdose: Q&A with Esther Mae Rosner On January 27, Vital Strategies’ Overdose Prevention Program hosted a naloxone training in our New York office to educate staff on the opioid epidemic and what they can do in their communities to prevent fatal overdose and help save lives. We sat down with Esther Mae Rosner, Program Officer of Vital Strategies’ Overdose Prevention Program, to learn more about naloxone and the importance of these trainings.
Expert Q&A Multidrug-Resistant TB: The Future of Treatment While TB incidence has slowly declined in recent years, there is still a significant need to identify, treat, and prevent this disease.
Expert Q&A Vital Stories Beating Air Pollution on World Environment Day: Q&A with Dan Kass More than 92% of the world’s population is exposed to poor air quality. Air pollution is the fifth leading risk factor for death and accounts for more than 5 million deaths each year globally.
Expert Q&A Vital Stories Turning the Tide on the U.S. Drug Overdose Epidemic: 8 Questions with Daliah Heller We sat down with Daliah Heller, Director of Drug Use Initiatives at Vital Strategies, to get her thoughts on what actions can be taken to reverse the country’s drug overdose crisis.
Expert Q&A Tobacco’s Goliath-Sized Threat to Public Health Among the things we can take some credit for are saving 35 million lives thanks to national policy wins banning indoor smoking, restricting tobacco advertising and higher taxes in Russia, India, Bangladesh, and Turkey.